Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.67)
# 787
Out of 5,056 analysts
137
Total ratings
55.22%
Success rate
4.56%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $4.00 | +200.00% | 1 | Nov 12, 2025 | |
| HCA HCA Healthcare | Maintains: Outperform | $400 → $500 | $478.14 | +4.57% | 12 | Oct 27, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $27.91 | +7.49% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $435.33 | +33.23% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $313.58 | +3.64% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $36.93 | +16.44% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $234.10 | +32.42% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $272.61 | +37.56% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.00 | +71.43% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $26.18 | +41.33% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $178.50 | -5.88% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $107.65 | +34.70% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $14.43 | +177.20% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.92 | +71.23% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.07 | - | 2 | Mar 7, 2024 |
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $4.00
Upside: +200.00%
HCA Healthcare
Oct 27, 2025
Maintains: Outperform
Price Target: $400 → $500
Current: $478.14
Upside: +4.57%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $27.91
Upside: +7.49%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $435.33
Upside: +33.23%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $313.58
Upside: +3.64%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $36.93
Upside: +16.44%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $234.10
Upside: +32.42%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $272.61
Upside: +37.56%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.00
Upside: +71.43%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $26.18
Upside: +41.33%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $178.50
Upside: -5.88%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $107.65
Upside: +34.70%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $14.43
Upside: +177.20%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.92
Upside: +71.23%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.07
Upside: -